Trial ID or NCT#





The investigators propose that patients who receive targeted pharmacotherapy (sertraline) or focused psychotherapy (cognitive behavioral therapy-informed psychotherapy (CBT-ip) for NES) or combined treatment (CBT-ip + sertraline) will report fewer nonepileptic seizures (NES) compared to patients who receive community care / treatment as usual (TAU). The purpose of this study is to provide pilot testing and data to inform the future multicenter randomized controlled trial based on the hypothesis.

Official Title

Medication and Psychotherapy Treatment Trial for Psychogenic Nonepileptic Seizures

Eligibility Criteria

Ages Eligible for Study: 18 Years to 95 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Charles Debattista
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult) at the Stanford University Medical Center
Kim Bullock, MD
Psychiatrist, Neuropsychiatrist, Psychotherapist
Clinical Associate Professor, Psychiatry and Behavioral Sciences

Contact us to find out if this trial is right for you.


Jessica Hawkins
(650) 723-8323